July 12, 2014 4:27 AM ET

Pharmaceuticals

Company Overview of Tioga Pharmaceuticals, Inc.

Executive Profile

David M. Urso Esq.

Senior Vice President of Corporate Development and General Counsel, MEI Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.

----

Background

Mr. David M. Urso, Esq. has been Senior Vice President of Corporate Development and General Counsel at MEI Pharma, Inc. since April 8, 2014. Mr. Urso has more than two decades of experience in the life science industry. Mr. Urso has a scientific background in molecular immunology and has experience in corporate securities and intellectual property transactions in the life science industry. He served as Chief Operating Officer and General Counsel at Tioga Pharmaceuticals, ...

Corporate Headquarters

9393 Towne Centre Drive
San Diego, California 92121

United States

Phone: 858-677-6077
Fax: 858-452-8799

Board Members Memberships

Chief Operating Officer and General Counsel

Education

BA
Reed College
JD
Harvard Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tioga Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.